SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001654954-18-011232
Filing Date
2018-10-16
Accepted
2018-10-16 16:05:49
Documents
10
Period of Report
2018-10-10
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ndra_8k.htm 8-K 33184
2 UNDERWRITING AGREEMENT ndra_ex1-1.htm EX-1.1 179996
3 OPINION OF K&L GATES LLP ndra_ex5-1.htm EX-5.1 11054
4 PRESS RELEASE, DATED OCTOBER 10, 2018 ndra_ex99-1.htm EX-99.1 14126
5 PRESS RELEASE, DATED OCTOBER 11, 2018 ndra_ex99-2.htm EX-99.2 14721
6 PRESS RELEASE, DATED OCTOBER 15, 2018 ndra_ex99-3.htm EX-99.3 14324
7 IMAGE ndra_ex5-1000.jpg GRAPHIC 1689
8 IMAGE ndra_ex99-1000.jpg GRAPHIC 6836
9 IMAGE ndra_ex99-2000.jpg GRAPHIC 6836
10 IMAGE ndra_ex99-3000.jpg GRAPHIC 6836
  Complete submission text file 0001654954-18-011232.txt   299824
Mailing Address 3600 GREEN COURT SUITE 350 ANN ARBOR MI 48105
Business Address 3600 GREEN COURT SUITE 350 ANN ARBOR MI 48105 734-335-0468
ENDRA Life Sciences Inc. (Filer) CIK: 0001681682 (see all company filings)

IRS No.: 260579295 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37969 | Film No.: 181124523
SIC: 3845 Electromedical & Electrotherapeutic Apparatus